Loading...
Oakridge International Limited
U9O0.F•XETRA
Healthcare
Medical - Healthcare Information Services
€0.03
€0.00(0.00%)
Oakridge International Limited (U9O0.F) Financial Performance & Statements
Review Oakridge International Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-25.78%
↓ 25.78%
Operating Income Growth
32.50%
↑ 32.50%
Net Income Growth
-555.62%
↓ 555.62%
Operating Cash Flow Growth
-28.00%
↓ 28.00%
Operating Margin
-43.71%
↓ 43.71%
Gross Margin
11.51%
↑ 11.51%
Net Profit Margin
-64.68%
↓ 64.68%
ROE
-81.70%
↓ 81.70%
ROIC
-42.14%
↓ 42.14%
Oakridge International Limited (U9O0.F) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Oakridge International Limited stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $832547.00 | $344482.00 | $697981.00 | $399751.00 |
| Cost of Revenue | $522493.00 | $519101.00 | $562204.00 | $446533.00 |
| Gross Profit | $310054.00 | -$174619.00 | $135777.00 | -$46782.00 |
| Gross Profit Ratio | $0.37 | -$0.51 | $0.19 | -$0.12 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $259195.00 | $390763.00 | $332648.00 | $362556.00 |
| Operating Expenses | $259195.00 | $390763.00 | $332648.00 | $262446.00 |
| Total Costs & Expenses | $781688.00 | $909865.00 | $894852.00 | $708983.00 |
| Interest Income | $2327.00 | $4679.00 | $9033.00 | $4390.00 |
| Interest Expense | $37271.00 | $5031.00 | $15642.00 | $12153.00 |
| Depreciation & Amortization | -$28819.00 | $43670.00 | $32300.00 | $2095.00 |
| EBITDA | -$140428.00 | -$411109.00 | -$24409.00 | -$292027.00 |
| EBITDA Ratio | -$0.17 | -$1.51 | -$0.24 | -$0.77 |
| Operating Income | $50859.00 | -$565380.00 | -$196870.00 | -$309230.00 |
| Operating Income Ratio | $0.06 | -$1.64 | -$0.28 | -$0.77 |
| Other Income/Expenses (Net) | -$528682.00 | -$67356.00 | -$45380.00 | $2954.00 |
| Income Before Tax | -$477823.00 | -$459809.00 | $40425.00 | -$306278.00 |
| Income Before Tax Ratio | -$0.57 | -$1.33 | $0.06 | -$0.77 |
| Income Tax Expense | -$176384.00 | $0.00 | $0.00 | -$149741.00 |
| Net Income | -$301439.00 | -$459809.00 | $40425.00 | -$156537.00 |
| Net Income Ratio | -$0.36 | -$1.33 | $0.06 | -$0.39 |
| EPS | -$0.01 | -$0.03 | $0.002 | -$0.009 |
| Diluted EPS | -$0.01 | -$0.03 | $0.002 | -$0.009 |
| Weighted Avg Shares Outstanding | $20.03M | $17.60M | $17.20M | $17.20M |
| Weighted Avg Shares Outstanding (Diluted) | $20.03M | $17.60M | $17.20M | $17.20M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan